Cyclosporin a regulates interleukin-1ß and interleukin-6 expression in gingiva: Implications for gingival overgrowth

Journal of Periodontology

Volumn 70, Issue 3, 1999, Pages 294-300

  Myrillas, Theofilos T ^b   Linden, Gerard J ^b   Marley, John J ^b   Irwin, Chris R ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Cyclosporin A; Cytokines; Gingival hyperplasia etiology; Interleukin 1; Interleukin 6

Indexed keywords

CYCLOSPORIN A; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ARTICLE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLAST; GINGIVA OVERGROWTH; GRAFT VERSUS HOST REACTION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MONONUCLEAR CELL; PROTEIN EXPRESSION;

ADULT; CELLS, CULTURED; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GENE EXPRESSION REGULATION; GINGIVA; GINGIVAL HYPERPLASIA; GINGIVAL OVERGROWTH; GINGIVITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 0032925995     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.3.294     Document Type: Article

References (52)

1. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992;357:695-697.
2. Hefti AF, Eshenaur AE, Hassell TM, Stone C. Gingival overgrowth and cyclosporin A treated multiple sclerosis patients. J Periodontol 1994;65:744-749.
3. Rostock MH, Fry HR, Turner JE. Severe gingival overgrowth associated with cyclosporin therapy. J Periodontol 1986;57:294-299.
4. Mariani G, Calastrini C, Carinci F, Bergamini L, Calastrini F, Stabellini G. Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth. J Periodontol 1996;67:21-27.
5. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporin A in vitro. J Periodont Res 1989;24:314-321.
6. Barber MT, Savage NW, Seymour GJ. The effect of cyclosporin and LPS on fibroblasts: Implications for cyclosporin induced gingival overgrowth. J Periodontol 1992;63:397-404.
7. Schincaglia GP, Forniti F, Cavallini R, Piva R, Calura G, del Senno L. Cyclosporin A increases type 1 procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21:181-185.
8. James JA, Irwin CR, Linden GJ. The effects of culture environment on the response of human gingival fibroblasts to cyclosporin A. J Periodontol 1995;66:339-344.
9. Newell J, Irwin CR. Comparative effects of cyclosporin on glycosaminoglycan synthesis by gingival fibroblasts. J Periodontol 1997;68:443-447.
10. Howells GL. Cytokine networks in destructive periodontal disease. Oral Dis 1995;1:266-270.
11. Murphy G, Reynolds JJ, Werb Z. Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-0-tetradecanoylphorbol 13-acetate and interleukin-1 in parallel with collagenase. J Biol Chem 1985;269:3079-3083.
12. Meikle MC, Atkinson SJ, Ward RV, et al. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin-1: Evidence that breakdown is mediated by metalloproteinases. J Periodont Res 1989;24:207-213.
13. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
14. Irwin CR, Myrillas TT. The role of IL-6 in the pathogenesis of periodontal disease. Oral Dis 1998;4:43-47.
15. Ishimi Y, Miyaura C, Jin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-3303.
16. Geivelis M, Tuner DW, Pederson ED, Lamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993;64:980-983.
17. Sato T, Ito A, Mori Y. Interleukin 6 enhances the production of tissue inhibitor of metalloproteinases (TIMP) but not that of matrix metalloproteinases by human fibroblasts. Biochem Biophys Res Commun 1990;170:824-829.
18. Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem 1991;266:2017-2020.
19. Lacraz S, Nicod L, Galve de-Rochemonteix B, Baumberger C. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992;90:382-388.
20. Shingu M, Nagai Y, Isayama T, et al. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 1993;94:145-149.
21. Roeb E, Graeve L, Hoffmann R, et al. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatol 1993;18:1437-1442.
22. Schindler R, Mancilla J, Endres S, et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-47.
23. Tilg H, Trehu E, Atkins MB, et al. Interleukin 6 as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-118.
24. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
25. Yakovlev E, Kalichman I, Pisanti S, Shoshan S, Barak V. Levels of cytokines and collagen type I and type III as a function of age in human gingivitis. J Periodontol 1996;67:788-793.
26. Williamson MS, Miller EK, Plemmons J, Rees TD, Iacopino AM. Cyclosporin A upregulates interleukin-6 expression in human gingiva: Possible mechanism for gingival overgrowth. J Periodontol 1994;65:895-903.
27. Takahashi K, Takashiba S, Nagai A, et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease. J Periodontol 1994;65:147-153.
28. Yamazaki K, Nakajima T, Gemmell E, et al. IL-4 and IL-6 producing cells in human periodontal disease tissue. J Oral Pathol Med 1994;23:347-353.
29. Matsuki Y, Yamamoto T, Hara K. Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry. Immunol 1992;76:42-47.
30. Tanner JE, Menezes J. Interleukin-6 and Epstein-Barr virus induction by cyclosporin A: Potential role in lymphoproliferative disease. Blood 1994;84:3956-3964.
31. Akagi H, Reynold A, Hjelm M. Cyclosporin A and its metabolites, distribution in blood and tissues. J Int Med Res 1991;19:1-18.
32. McGaw WT, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlations with dental plaque scores, gingivitis scores and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
33. Page RC, Ammons WF. Collagen turnover in the gingiva and other mature connective tissues of the marmoset Saguinus Oedipus. Arch Oral Biol 1974;19:651-658.
34. Grossman R M, Krueger J, Yourish, D, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci (USA) 1989;86:6367-6371.
35. Belazi M, Thomopoulos GN, Markopoulos AK, Papanayotou P. Cyclosporin-A induced gingival hyperplasia: An ultrastructural study of the oral epithelial prickle cells. J Submicrosc Cytol Pathol 1993;25:591-601.
36. James JA, Irwin CR, Linden GJ. Gingival fibroblast response to cyclosporin A and transforming growth factor ß1. J Periodont Res 1998;33:40-48.
37. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM. Cyclosporin A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996;67:271-278.
38. Ahuja SS, Shrivastav S, Danielpour D, Balow JE, Boumpas DT. Regulation of transforming growth factor-beta (1) and its receptor by cyclosporin in human T-lymphocytes. Transplantation 1995;60:718-723.
39. Wolf G, Thaiss F, Stahl RAK. Cyclosporin stimulates expression of transforming growth factor-beta in renal cells - possible mechanism of cyclosporine's antiproliferative effects. Transplantation 1995;60:237-241.
40. Prashar Y, Khanna A, Sehajpal P, Sharma VK, Suthanthiran M. Stimulation of transforming growth factor-beta (1) transcription by cyclosporin. FEBS Lett 1995;358:109-112.
41. Koka S, Maze C, Rheinhardt R, Dyer J. Variability of inflammatory mediator production by human periodontal fibroblasts stimulated with bacterial lipopolysaccharide. In Vitro Cell Dev Biol 1996;32:528-530.
42. Simsey-Durrant HJ, Hopps R. Effect of Porphyromonas gingivalis on prostaglandin E2 and interleukin-1ß release from rat periosteal and human gingival fibroblasts in vitro. Oral Microbiol Immunol 1991;6:378-380.
43. Agarwal S, Baran C, Piesco NP, et al. Synthesis of proinflammatory cytokines by human gingival fibroblasts in response to lipopolysaccharides and interleukin-1ß. J Periodont Res 1995;30:382-389.
44. Reddi K, Wilson M, Nair S, Poole S, Henderson B. Comparison of the pro-inflammatory cytokine-stimulating activity of the surface-associated proteins of periodontopathic bacteria. J Periodont Res 1996;31:120-130.
45. Takada H, Mihara J, Morisaki I, Hamada S. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect Immun 1991;59:295-301.
46. Hassell TM, Stanek EJ. Evidence that healthy human gingiva contains functionally heterogenous fibroblast subpopulations. Arch Oral Biol 1983;28:617-625.
47. Irwin CR, Picardo M, Ellis I, et al. Inter- and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: Potential significance for wound healing. J Cell Sci 1994;107:1333-1346.
48. Hassell TM. Evidence for the production of inactive collagenase by fibroblasts from phenytoin-enlarged human gingivae. J Oral Pathol Med 1982;11:310-317.
49. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporin A in vitro. J Periodont Res 1989;24:314-321.
50. Tipton DA, Fry HR, Dabbous KH. Altered collagen metabolism in nifedipine-induced gingival overgrowth. J Periodont Res 1994;29:401-409.
51. McKevitt KMB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingival tissue. J Oral Pathol Med 1995;24:66-71.
52. Zebrowski EJ, Pylypas SP, Odium O, Johnson RB. Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporin. J Periodontol 1994;65:565-567.